(D-His2)-Leuprolide Trifluoroacetic Acid Salt features a stereochemical substitution at position two, modifying receptor-contact geometry and backbone folding. The peptide's aromatic and charged residues support structural studies of ligand dynamics. Researchers employ it to investigate conformation-driven recognition and helix formation. Its TFA form improves solubility and handling.
CAT No: R2262
CAS No:112642-11-2
Synonyms/Alias:12642-11-2;(D-His2)-Leuprolide Trifluoroacetic Acid Salt;(Des-Gly10,D-His2,D-Leu6,Pro-NHEt9)-LHRH;MFCD02264520;D-HIS-LEUPROLIDE;TN3XE824EM;FD109240;(Des-Gly10,D-His2,D-Leu6,Pro-NHEt 9)-LHRH;Pyr-D-His-Trp-Ser-Tyr-D-Leu-Leu-Arg-Pro-NHEt; pE-(dH)WSY(dL)LRP-NHEt;5-OXO-L-PROLYL-D-HISTIDYL-L-TRYPTOPHYL-L-SERYL-L-TYROSYL-D-LEUCYL-L-LEUCYL-L-ARGINYL-N-ETHYL-L-PROLINAMIDE; (S)-1-((3R,6S,9S,12S,15R,18S,21S)-3-((1H-imidazol-5-yl)methyl)-6-((1H-indol-3-yl)methyl)-21-(3-guanidinopropyl)-12-(4-hydroxybenzyl)-9-(hydroxymethyl)-15,18-diisobutyl-1,4,7,10,13,16,19-heptaoxo-1-((S)-5-oxopyrrolidin-2-yl)-2,5,8,11,14,17,20-heptaazadocosan-22-oyl)-N-ethylpyrrolidine-2-carboxamide; (D-His2)-Leuprolide
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.